Strategic Financial Concepts’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,198
Closed -$19.3K 772
2024
Q1
$19.3K Buy
+14,198
New +$30.2K ﹤0.01% 311
2023
Q4
Sell
-14,198
Closed -$45.4K 152
2023
Q3
$45.4K Hold
14,198
0.02% 264
2023
Q2
$71.4K Buy
14,198
+1,000
+8% +$5.07K 0.03% 252
2023
Q1
$38K Buy
+13,198
New +$38.5K 0.02% 240

Other funds holding APYX

Strategic Financial Concepts's APYX Position: Q2 2024 in Review

Strategic Financial Concepts sold out of Apyx Medical (APYX) in Q2 2024, closing a stake of 14,198 shares — an estimated $19.3K sold.

Strategic Financial Concepts first reported a position in APYX in Q1 2023 and held it in 4 quarters. The position peaked at $71.4K in Q2 2023. 49 funds tracked by Wall St. Rank hold APYX as of Q2 2024.

  • Strategic Financial Concepts reported no remaining Apyx Medical position as of Q2 2024 after selling out during the quarter.
  • Strategic Financial Concepts sold 14,198 Apyx Medical shares in Q2 2024, an estimated $19.3K.
  • Strategic Financial Concepts first reported a position in Apyx Medical in Q1 2023 and held it in 4 quarters.
  • Strategic Financial Concepts's Apyx Medical position peaked at $71.4K in Q2 2023.
  • 49 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2024.

Based on Strategic Financial Concepts's 13F filing for Q2 2024, filed 6 Aug 2024.